Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Quantitative Profiling of Platelet-Rich Plasma Indole Markers by Direct-Matrix Derivatization Combined with LC-MS/MS in Patients with Neuroendocrine Tumors.

van Faassen M, Bouma G, de Hosson LD, Peters MAM, Kats-Ugurlu G, de Vries EGE, Walenkamp AME, Kema IP.

Clin Chem. 2019 Nov;65(11):1388-1396. doi: 10.1373/clinchem.2019.305359. Epub 2019 Sep 24.

PMID:
31551315
2.

Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT.

de Hosson LD, van der Loo-van der Schaaf AM, Boellaard R, van Snick JH, de Vries EGE, Brouwers AH, Walenkamp AME.

Clin Nucl Med. 2019 Aug;44(8):612-619. doi: 10.1097/RLU.0000000000002640.

PMID:
31274606
3.

Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT.

de Hosson LD, van der Loo-van der Schaaf AM, Boellaard R, van Snick JH, de Vries EGE, Brouwers AH, Walenkamp AME.

Clin Nucl Med. 2019 Jun 13. doi: 10.1097/RLU.0000000000002640. [Epub ahead of print]

PMID:
31205146
4.

Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trial.

de Hosson LD, Bouma G, Stelwagen J, van Essen H, de Bock GH, de Groot DJA, de Vries EGE, Walenkamp AME.

Orphanet J Rare Dis. 2019 Feb 28;14(1):60. doi: 10.1186/s13023-019-1035-3.

5.

Use of Video-consultation is Feasible During Follow-up Care of Patients with a Neuroendocrine Tumour.

Bouma G, de Hosson LD, van Essen H, de Vries EGE, de Groot DJA, Walenkamp AME.

Clin Oncol (R Coll Radiol). 2018 Jun;30(6):396. doi: 10.1016/j.clon.2018.02.027. Epub 2018 Mar 3. No abstract available.

PMID:
29506774
6.

Towards optimal personalized diet and vitamin supplementation in NET patients.

de Hosson LD, Stelwagen J, Bouma G, Sijtema B, Huitema S, van Faassen HJR, de Bock GH, de Groot DJA, Campmans-Kuijpers MJE, Kema IP, de Vries EGE, Walenkamp AME.

Endocr Relat Cancer. 2018 Mar;25(3):L23-L26. doi: 10.1530/ERC-17-0549. No abstract available.

PMID:
29431642
7.

Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework.

de Hosson LD, van Veenendaal LM, Schuller Y, Zandee WT, de Herder WW, Tesselaar MET, Kl├╝mpen HJ, Walenkamp AME.

Ann Oncol. 2017 Dec 1;28(12):3022-3027. doi: 10.1093/annonc/mdx547. Review.

PMID:
29045525
8.

Web-based information and support for patients with a newly diagnosed neuroendocrine tumor: a feasibility study.

Bouma G, de Hosson LD, van Woerkom CE, van Essen H, de Bock GH, Admiraal JM, Reyners AKL, Walenkamp AME.

Support Care Cancer. 2017 Jul;25(7):2075-2083. doi: 10.1007/s00520-017-3598-7. Epub 2017 Feb 9.

9.

Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature.

de Hosson LD, van de Warrenburg BP, Preijers FW, Blijlevens NM, van der Reijden BA, Kremer HP, Lefeber DJ, Allebes WA, Al-Ali H, Niederwieser DW, Schaap NP, Schattenberg AV.

Bone Marrow Transplant. 2011 Aug;46(8):1071-6. doi: 10.1038/bmt.2010.252. Epub 2010 Nov 1. Review.

PMID:
21042305

Supplemental Content

Loading ...
Support Center